These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34740843)

  • 1. Macrophages in tumor: An inflammatory perspective.
    Goswami KK; Bose A; Baral R
    Clin Immunol; 2021 Nov; 232():108875. PubMed ID: 34740843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Associated Macrophages in Tumor Immunity.
    Pan Y; Yu Y; Wang X; Zhang T
    Front Immunol; 2020; 11():583084. PubMed ID: 33365025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Integrative Analysis Reveals the Association of
    Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic studies of tumor-associated macrophage immunotherapy.
    Cao J; Liu C
    Front Immunol; 2024; 15():1476565. PubMed ID: 39403370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update to experimental and clinical aspects of tumor-associated macrophages in cancer development: hopes and pitfalls.
    Salmaninejad A; Layeghi SM; Falakian Z; Golestani S; Kobravi S; Talebi S; Yousefi M
    Clin Exp Med; 2024 Jul; 24(1):156. PubMed ID: 39003350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 7. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy.
    Toledo B; Zhu Chen L; Paniagua-Sancho M; Marchal JA; Perán M; Giovannetti E
    J Hematol Oncol; 2024 Jun; 17(1):44. PubMed ID: 38863020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
    Gao J; Liang Y; Wang L
    Front Immunol; 2022; 13():888713. PubMed ID: 35844605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Associated Macrophages and Their Functional Transformation in the Hypoxic Tumor Microenvironment.
    He Z; Zhang S
    Front Immunol; 2021; 12():741305. PubMed ID: 34603327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy.
    Rodriguez-Garcia A; Lynn RC; Poussin M; Eiva MA; Shaw LC; O'Connor RS; Minutolo NG; Casado-Medrano V; Lopez G; Matsuyama T; Powell DJ
    Nat Commun; 2021 Feb; 12(1):877. PubMed ID: 33563975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
    Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
    J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials.
    Zhang W; Wang M; Ji C; Liu X; Gu B; Dong T
    Biomed Pharmacother; 2024 Aug; 177():116930. PubMed ID: 38878638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer.
    Zhu X; Liang R; Lan T; Ding D; Huang S; Shao J; Zheng Z; Chen T; Huang Y; Liu J; Pathak JL; Wei H; Wei B
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs: As Critical Regulators of Tumor- Associated Macrophages.
    Chatterjee B; Saha P; Bose S; Shukla D; Chatterjee N; Kumar S; Tripathi PP; Srivastava AK
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated macrophages: an effective player of the tumor microenvironment.
    Basak U; Sarkar T; Mukherjee S; Chakraborty S; Dutta A; Dutta S; Nayak D; Kaushik S; Das T; Sa G
    Front Immunol; 2023; 14():1295257. PubMed ID: 38035101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular understanding and clinical aspects of tumor-associated macrophages in the immunotherapy of renal cell carcinoma.
    Liu H; Lv Z; Zhang G; Yan Z; Bai S; Dong D; Wang K
    J Exp Clin Cancer Res; 2024 Aug; 43(1):242. PubMed ID: 39169402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polarization of M2 Tumor-Associated Macrophages (TAMs) in Cancer Immunotherapy.
    Bui I; Bonavida B
    Crit Rev Oncog; 2024; 29(4):75-95. PubMed ID: 38989739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk Between Macrophages and Breast Cancer Cells: Networking Within Tumors.
    Melwani PK; Checker R; Balla MMS; Pandey BN
    Results Probl Cell Differ; 2024; 74():213-238. PubMed ID: 39406907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Antigen Presentation in Tumor-Associated Macrophages.
    Stopforth RJ; Ward ES
    Crit Rev Immunol; 2020; 40(3):205-224. PubMed ID: 33389885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.